Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Acute myeloid leukemia outcome: role of nucleotide excision repair polymorphisms in intermediate risk patients.

Leukemia & lymphoma - 1 Apr 2010

Strom Sara S, Estey Elihu, Outschoorn Ubaldo Martinez, Garcia-Manero Guillermo

Abstract excerpt

In acute myeloid leukemia (AML), cytogenetics predicts treatment outcome for the favorable and poor subgroups but not for the intermediate subgroup. Polymorphisms within the nucleotide excision repair (NER) pathway may lead to interindividual differences in DNA repair capacity, influencing outcom...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA-Binding Proteins
Share to DNA Repair
Share to Endonucleases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leukemia, Myeloid, Acute

Share to Nuclear Proteins

Share to Prognosis

Share to Survival Analysis

Share to Xeroderma Pigmentosum Group D Protein

Source

Open in PubMed Open full text

Identifiers

PMID: 20141440
DOI: 10.3109/10428190903582804
PMCID: PMC2918264

Genes

XPC
CCNH
ERCC1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20141440-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Acute myeloid leukemia outcome: role of nucleotide excision repair polymorphisms in intermediate risk patients.PMID 20141440Read ↗

Genetic variants of nucleotide excision repair pathway and outcomes of induction therapy in acute myeloid leukemia.Semantic proximity Read ↗

XPD gene polymorphisms and the effects of induction chemotherapy in cytogenetically normal de novo acute myeloid leukemia patients.Semantic proximity Read ↗

Polymorphisms in DNA repair genes and therapeutic outcomes of AML patients from SWOG clinical trials.Semantic proximity Read ↗

Genetic variations in DNA excision repair pathway contribute to the chemosensitivity and prognosis of acute myeloid leukemia.Semantic proximity Read ↗

Genetic variations of DNA repair genes and their prognostic significance in patients with acute myeloid leukemia.Semantic proximity Read ↗

Genomic polymorphisms provide prognostic information in intermediate-risk acute myeloblastic leukemia.Semantic proximity Read ↗

Polymorphisms in XPC provide prognostic information in acute myeloid leukemia.Semantic proximity Read ↗

XRCC1 Arg194Trp and Arg399Gln polymorphisms are significantly associated with shorter survival in acute myeloid leukemia.Semantic proximity Read ↗

Role of XRCC3, XRCC1 and XPD single-nucleotide polymorphisms in survival outcomes following adjuvant chemotherapy in early stage breast cancer patients.Semantic proximity Read ↗

Nucleotide excision repair polymorphisms and survival outcome for patients with metastatic breast cancer.Semantic proximity Read ↗

DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.Semantic proximity Read ↗

5'-nucleotidase, cytosolic II genotype, and clinical outcome in patients with acute myeloid leukemia with intermediate-risk cytogenetics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.